News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,592 Results
Type
Article (39536)
Company Profile (309)
Press Release (650747)
Section
Business (204826)
Career Advice (2009)
Deals (35485)
Drug Delivery (91)
Drug Development (81057)
Employer Resources (168)
FDA (16130)
Job Trends (14861)
News (345929)
Policy (32562)
Tag
Academia (2548)
Alliances (49523)
Alzheimer's disease (1262)
Approvals (16072)
Artificial intelligence (144)
Bankruptcy (354)
Best Places to Work (11598)
Biotechnology (217)
Breast cancer (189)
Cancer (1355)
Cardiovascular disease (110)
Career advice (1676)
Cell therapy (276)
Clinical research (64787)
Collaboration (469)
Compensation (255)
COVID-19 (2558)
C-suite (110)
Data (1373)
Diabetes (168)
Diagnostics (6189)
Earnings (85016)
Employer resources (146)
Events (110491)
Executive appointments (384)
FDA (16778)
Funding (423)
Gene therapy (195)
GLP-1 (598)
Government (4346)
Healthcare (18710)
Infectious disease (2649)
Inflammatory bowel disease (115)
Interviews (309)
IPO (16366)
Job creations (3660)
Job search strategy (1430)
Layoffs (421)
Legal (7896)
Lung cancer (197)
Manufacturing (200)
Medical device (13221)
Medtech (13226)
Mergers & acquisitions (19262)
Metabolic disorders (444)
Neuroscience (1579)
NextGen Class of 2024 (6535)
Non-profit (4479)
Northern California (1677)
Obesity (254)
Opinion (187)
Patents (116)
People (56765)
Phase I (20168)
Phase II (28542)
Phase III (21260)
Pipeline (511)
Postmarket research (2561)
Preclinical (8580)
Radiopharmaceuticals (236)
Rare diseases (256)
Real estate (5936)
Regulatory (21711)
Research institute (2318)
Resumes & cover letters (350)
Southern California (1453)
Startups (3614)
United States (15039)
Vaccines (564)
Weight loss (180)
Date
Today (128)
Last 7 days (559)
Last 30 days (2542)
Last 365 days (35397)
2024 (34901)
2023 (40184)
2022 (51292)
2021 (55836)
2020 (54163)
2019 (46651)
2018 (35128)
2017 (32224)
2016 (31629)
2015 (37708)
2014 (31457)
2013 (26501)
2012 (28774)
2011 (29427)
2010 (27525)
Location
Africa (716)
Arizona (194)
Asia (37461)
Australia (6130)
California (3782)
Canada (1433)
China (298)
Colorado (171)
Connecticut (175)
Europe (80313)
Florida (529)
Georgia (133)
Illinois (383)
Indiana (224)
Kansas (97)
Maryland (621)
Massachusetts (2943)
Michigan (170)
Minnesota (287)
New Jersey (1084)
New York (1067)
North Carolina (737)
Northern California (1677)
Ohio (147)
Pennsylvania (916)
South America (1094)
Southern California (1453)
Texas (544)
Utah (105)
Washington State (397)
690,592 Results for "cleave biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 3, 2024
·
5 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
December 3, 2024
·
5 min read
Press Releases
Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
November 22, 2024
·
5 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
December 17, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Press Releases
Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity Financing
December 3, 2024
·
7 min read
Business
Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets
Cleave Therapeutics, Inc. today announced that CASI Pharmaceuticals (NASDAQ: CASI) has acquired the global rights to the company’s clinical asset, CB-5339, and Eikon Therapeutics has acquired rights to the company’s pre-clinical assets.
July 20, 2023
·
3 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
1 of 69,060
Next
